论文部分内容阅读
目的:探讨分析低分子肝素联合卡托普利治疗肾病综合征的疗效。方法:选取我院收治的肾病综合征患者59例作为观察对象,将其随机分为观察组(29例)和对照组(30例)。对照组患者采取常规药物治疗,观察组患者在常规治疗的基础之上给予低分子肝素联合卡托普利治疗。观察比较两组患者的临床治疗效果。结果:观察组患者的治疗效果明显优于对照组,两组之间的比较具有显著差异(p<0.05),具统计学意义。结论:低分子肝素联合卡托普利治疗肾病综合征,能有效提高患者的治疗效果,值得在临床上推广运用。
Objective: To investigate the effect of low molecular weight heparin combined with captopril in the treatment of nephrotic syndrome. Methods: Fifty-nine patients with nephrotic syndrome admitted to our hospital were selected as observation subjects and randomly divided into observation group (n = 29) and control group (n = 30). Control group of patients taking conventional drug treatment, observation group patients on the basis of conventional treatment given low molecular weight heparin combined captopril treatment. The clinical effects of two groups were observed and compared. Results: The therapeutic effect of the observation group was significantly better than that of the control group. The comparison between the two groups showed significant difference (p <0.05), with statistical significance. Conclusion: Low molecular weight heparin combined with captopril treatment of nephrotic syndrome, can effectively improve the therapeutic effect of patients, it is worth in the clinical application.